Melbourne, Australia - At the Annual General Meeting (Council) on July 9th, 2019 at ISTH 2019 Congress in Melbourne, Australia, INVENT Council endorsed four clinical VTE studies / trials. The following studies were endorsed by the Network:
- The REDUCE Study: Management of recurrent venous thromboembolism during anticoagulant treatment in cancer patients - a prospective cohort study.
- ADJUST-DVT: Age-adjusted D-dimer cut-off levels to rule out deep vein thrombosis - a prospective outcome study.
- Pilot PARTUM Trial- a pilot study assessing the feasibility of a randomized controlled trial evaluating aspirin in postpartum women at risk of developing venous thromboembolism.
- The RHEA Study: Optimizing diagnosis of splanchnic vein thrombosis with MR direct thrombus imaging
The INVENT Network has now endorsed 14 studies since its inception in 2016. For the complete list, please visit our website here.